Course Category: Expert Talk

Prof. Thomas Muenzel covers the impacts and effects that Environmental Hazards have on Cardiovascular Disease.

Professor Thomas Muenzel Background

Professor Muenzel is currently the Chairmain of the Department of Cardiology at the University Medical Centre in Mainz, Germany.

Prof. Muenzel had published vastly in vascular biology and cardiology, alike; He made major contributions in the molecular mechanism and clinical effects of nitroglycerin and most recently, has focused his interest on environmental injuries on the cardiovascular system and its implications for cardiovascular health and disease; he has really pioneered this field that is currently centre stage worldwide. Based on his work he coined the term “exposome” as a new focus in cardiovascular prevention including environmental injuries.

He also held a faculty position at the University Hospital Eppendorf, Hamburg and has help his position since 2004.

Tags Cardiology

SARCOIDOSIS IN PRIMARY CARE

This short talk on “Sarcoidosis in Primary Care” aims to assist general practitioners to consider sarcoidosis as a possible explanation for patients presenting with typical as well as non-specific symptoms and signs suggestive of this disease.

Early consideration of sarcoidosis as a possibility and referral to specialist sarcoidosis centres by GPs could prevent progression of symptoms and speed up the identification of extra pulmonary complications that can be life-threatening

DR. VASILIS KOURANOS BACKGROUND

Dr Vasilis Kouranos completed his training in respiratory medicine in 2013 at the General Hospital of Thoracic Diseases, in Athens, Greece.

In addittion, he completed his PhD at the University of Athens focused on screening CMR patients with biopsy-proven sarcoidosis. He was awarded a research scholarship for the study and his PhD was awarded in 2017 after his work was published in a high-impact journal.

Dr Kouranos joined the Royal Brompton hospital as a clinical research fellow to Professor Athol Wells. In 2016 he started the role of senior clinical fellow while he was acting consultant in the interstitial lung disease department.

Moreover, he has great experience in management of patients with sarcoidosis, interstitial lung disease and pulmonary fibrosis.

Read more: here

IRON MAN TRIAL OBJECTIVES

The Ironman trial examines the connection between patients with heart failure, reduced left ventricular ejection fraction, iron deficiency, intravenous ferric carboxymaltose administration and whether it improves quality of life and exercise capacity in the short term and reduces hospital admissions for heart failure up to one year. This study aimed to evaluate the longer-term effects of intravenous ferric derisomaltose on cardiovascular events in patients with heart failure.

PROFESSOR PAUL KALRA BACKGROUND

This Grand Round is presented by Professor Paul Kalra. Professor Kalra started as a Consultant Cardiologist at Portsmouth Hospitals NHS Trust in April 2004. In 2019 he was appointed as Honorary Professor of Cardiology.

He is Chief Investigator for the BHF funded Ironman trial study evaluating the role of intravenous iron in patients with heart failure (IRONMAN – 75 UK centres), which has the potential to shape international guidelines and clinical practice.

Whilst he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. He has championed local heart failure service development spanning primary, secondary and tertiary care. In addition, he co-developed the local complex device service, initiating local implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy device (CRT) implantation and follow up. Paul has extensive expertise in assessment of patients for and the implantation of pacemakers and other complex devices (CRT and ICD).

Paul has been on the British Society for Heart Failure Board since 2009 and was elected Chair 2017-2019 (now past chair). This is the national body providing expert advice, support and education to NHS organizations, professionals and patients (working closely with patient groups). During his role as Chair he was instrumental in getting heart failure recognised as a priority and incorporated into the NHS Long Term Plan published in 2019. He is currently helping to drive implementation of change, contributing to NHS England’s NHS Long Term Plan Heart Failure and Heart Valve Disease Expert Advisory Group. He has helped set up and is vice-chair of the committee for the British Heart Foundation (BHF) ‘hope for hearts’ innovation fund (up to £1 million to help support innovation to help deliver better heart failure care).

In 2019 the UK’s largest heart failure patient charity, Pumping Marvellous Foundation, presented Paul with the Platinum patient educator award – recognising extraordinary work towards building awareness of heart failure and advocacy of better systems to improve care for patients.

He is committed to medical education and has helped organise regular national meetings (see www.bsh.org.uk and www.cardiorenalforum.com) for hospital doctors, GPs and specialist nurses. He actively contributes to education of cardiology trainees through roles with national (British Cardiovascular Society) and international (European Society for Cardiology) societies. This has included question writing and exam setting for the European Exam in General Cardiology for 10 years and in 2020 was appointed Chair of the UK standard setting group for this exam.

He has over 100 peer review publications and has edited a textbook ‘Specialist Training in Cardiology’ which was Highly Commended in the BMA Medical Book Competition.

Professor Pallav Shah covers bronchoscopy techniques and how these have evolved over time, providing insights into case studies.

This talk discusses lung disease and respiratory health related to pulmonary medicine, regarding the recent respiratory pandemic.

This talk provides insights into recent published work on the preliminary data on validation of critically ill COVID-19 patients.

This talk focuses on multi-disciplinary discussions around opportunistic targeted AF case findings, utilising innovative ECG technology and how digital transformation is set to change healthcare.

This talk provides insights into the crystal accumulation and mucus plugging as a driver of severe asthma of type 2 immunity.

Dr Rakesh Sharma provides an overview on the rising prevalence of cardiac sarcoidosis; how to diagnose and manage the disease.

This talk discusses the journeys through the different states of sleep and reality, whilst reviewing case studies.